Investigations Regarding B-cell Subsets in Humans

NCT00926692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 249

Last updated 2015-08-26

No results posted yet for this study

Summary

The aim of this research is to define the human equivalent of mouse B1 cells.

Conditions

  • Healthy

Interventions

OTHER

Blood draw

Subject will have blood draw.

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Daniel Griffin, M.D. · Feinstein Institute for Medical Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926692 on ClinicalTrials.gov